Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Concurrent Hysterectomy and Weight Loss Surgery in Obese Patients with Endometrial Cancer

Trial Status: active

This clinical trial studies whether obese or overweight patients with endometrial cancer can conveniently undergo simultaneous weight loss surgery with curative hysterectomy in a timely fashion. The most common risk factor for endometrial cancer is obesity. Weight loss surgery has been shown to help patients lose weight and also decrease their risk for obesity-related diseases. If patients with early-stage endometrial cancer or pre-cancer can undergo hysterectomy and weight loss surgery at the same time, their cancer may be cured and their risk for obesity-related diseases may be greatly decreased.